Your fact-checks will appear here
Diagnostics Accelerator initiative
–backed initiatives and investments favor a pluralistic, translational approach to Alzheimer’s therapeutics that explicitly includes small molecules and biologics but emphasizes newer mechanisms—mitoc...
Yes — Bill Gates (through Gates Ventures and personal initiatives) and allied philanthropic investments have funded biomarker research and programs that support clinical trials in Alzheimer’s disease,...
has committed personal and philanthropic capital to multiple Alzheimer’s initiatives that target early detection, diagnostics, data sharing and therapeutic pipelines, including multi‑million‑dollar in...
has deployed a mix of personal philanthropy and partnership funding to accelerate diagnostics, drug discovery and data-sharing, including a $100 million personal commitment, a $50 million investment i...